Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes
Tarloxotinib 是一种缺氧激活的泛 HER 激酶抑制剂，可有效对抗多种 HER 家族致癌基因
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-20-3555
Adriana Estrada-Bernal, Anh T Le, Andrea E Doak, Vijaya G Tirunagaru, Shevan Silva, Matthew R Bull, Jeff B Smaill, Adam V Patterson, Chul Kim, Stephen V Liu, Robert C Doebele
